Remimazolam. GABAA benzodiazepine site receptor agonist, anesthetic/sedativePiehl, E.
Remimazolam, also known as CNS-7056, is a novel, ultra- short-acting benzodiazepine. It has a faster onset and shorter duration of action than midazolam, with reliable metabolism to an inactive metabolite, CNS-7054, by plasma esterases. The sedative effects appear typical of benzodiazepines and are dependent on dose, with a wide therapeutic range.